Investor Outlook: Gene Therapy Picking up Steam; At a Crossroads

Human Gene Therapy Clinical Development

Volumn 27, Issue 3, 2016, Pages 87-92

  Schimmer, Joshua ^a   Breazzano, Steven ^a  

^a Piper Jaffray Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; GENE THERAPY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; MORBIDITY; MORTALITY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; BIOTECHNOLOGY; ECONOMICS; INVESTMENT;

BIOTECHNOLOGY; GENETIC THERAPY; HUMANS; INVESTMENTS;

EID: 84987892560     PISSN: 23248637     EISSN: 23248645     Source Type: Journal    
DOI: 10.1089/humc.2016.29017.ind     Document Type: Article

References (13)

1. uniQure. uniQure press releases. http://www. uniqure. com/news/latest-press-releases (last accessed August 8, 2016).
2. Spark Therapeutics. Spark press releases. http://ir. sparktx. com/phoenix. zhtml?c=253900&p=irol-news& nyo=0 (last accessed August 8, 2016).
3. BioMarin. BioMarin press releases. http://investors. bmrn. com/releases. cfm (last accessed August 8, 2016).
4. AveXis. AveXis press releases. http://investors. avexis. com/phoenix. zhtml?c=254285&p=irol-news& nyo=0 (last accessed August 8, 2016).
5. Voyager Therapeutics. Voyager Therapeutics press releases. http://ir. voyagertherapeutics. com/phoenix. zhtml?c=254026&p=irol-news&nyo=0 (last accessed August 8, 2016).
6. Schimmer J, Breazzano, S. Investor outlook: significance of the positive LCA2 gene therapy phase III results. Hum Gene Ther Clin Dev 2015;26:208-210.
7. Schimmer J, Breazzano, S. Investor outlook: rising from the ashes; GSK's European approval of Strimvelis for ADA-SCID. Hum Gene Ther Clin Dev 2016;27:57-61.
8. STAT. There's a possible cure for ''bubble boy'' disease. It will cost $665, 000. https://www. statnews. com/2016/08/03/gene-therapy-price-gsk/ (last accessed August 8, 2016).
9. Lozier J. Factor IX Padua: them that have, give. Blood 2012;120:4452-4453.
10. Ionis Pharmaceuticals. Ionis press releases. http:// ir. ionispharma. com/phoenix. zhtml?c=222170&p= irol-news&nyo=0 (last accessed August 8, 2016).
11. Kahmphuisen P, Eikenboom J, Bertina R. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001;21:731-738.
12. Roche. Roche investor updates. http://www. roche. com/investors/updates. htm (last accessed August 8, 2016).
13. Alnylam Pharmaceuticals. Alnylam press releases. http://investors. alnylam. com/releases. cfm (last accessed August 8, 2016).